Sanofi, SNY is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in France, Sanofi, SNY has a market cap of 99508.73. Since its IPO date on the 7/1/2002, Sanofi, SNY performance year to date is -5.52%. Today Sanofi, SNY has gained -0.10%, with a current price of 38.63.
Ownership of the company is 16.40% for insider ownership while institutional ownership is 10.30%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at *TBA, with return on investment at 6.50%.
In terms of debt levels and profit levels, Sanofi, SNY is seeing a long-term debt/equity of 0.27. While Total debt/equity is 0.32. With a profit margin of *TBA, this is combined with a gross margin of 68.90%, and operating margin of *TBA. Sanofi ability to meet debt levels, with a current ratio of 1.5, while the quick ratio is 1.
For the last year Sanofi, SNY has seen a EPS growth of 4.10%. A performance for the year of -15.75%. The 52-week high is -22.41%, and the 52-week low is 6.98%. The average volume for Sanofi, SNY is 1010443.
With a target price of 51.33, can Sanofi, SNY reach this target? Looking at the value indicators of Sanofi, SNY. Sanofi has a P/E of 21.45 and a forward P/E of 12.7. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.35. Sanofi also has a P/S and a P/B of 2.57 and 1.62 respectively. For P/cash, Sanofi has a value of 14.12, while it is *TBA for P/free cash flow.
At the current price of 38.63, Sanofi has a dividend yield of 4.29%. We see a return on equity of *TBA.
Looking more long-term Sanofi, is projected to get an EPS growth for the next five years of 6.40%. In the short-term an EPS growth of -1.62% in the next year is forecasted. This is after a EPS growth of 4.10% for this year and for the last five years a -4.40% growth has been seen.